Annual Gross Profit
$1.09 B
+$299.97 M+37.83%
December 31, 2023
Summary
- As of February 20, 2025, SRPT annual gross profit is $1.09 billion, with the most recent change of +$299.97 million (+37.83%) on December 31, 2023.
- During the last 3 years, SRPT annual gross profit has risen by +$616.28 million (+129.28%).
- SRPT annual gross profit is now at all-time high.
Performance
SRPT Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$375.48 M
+$57.09 M+17.93%
September 30, 2024
Summary
- As of February 20, 2025, SRPT quarterly gross profit is $375.48 million, with the most recent change of +$57.09 million (+17.93%) on September 30, 2024.
- Over the past year, SRPT quarterly gross profit has stayed the same.
- SRPT quarterly gross profit is now at all-time high.
Performance
SRPT Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$1.41 B
+$80.69 M+6.07%
September 30, 2024
Summary
- As of February 20, 2025, SRPT TTM gross profit is $1.41 billion, with the most recent change of +$80.69 million (+6.07%) on September 30, 2024.
- Over the past year, SRPT TTM gross profit has stayed the same.
- SRPT TTM gross profit is now at all-time high.
Performance
SRPT TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
SRPT Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +37.8% | 0.0% | 0.0% |
| 3 y3 years | +129.3% | +97.3% | +91.7% |
| 5 y5 years | +309.6% | +97.3% | +91.7% |
SRPT Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +80.7% | at high | +121.2% | at high | +133.0% |
| 5 y | 5-year | at high | +237.1% | at high | +344.1% | at high | +334.7% |
| alltime | all time | at high | >+9999.0% | at high | -100.0% | at high | -100.0% |
Sarepta Therapeutics Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $375.48 M(+17.9%) | $1.41 B(+6.1%) |
| Jun 2024 | - | $318.39 M(-12.3%) | $1.33 B(+7.4%) |
| Mar 2024 | - | $362.90 M(+2.9%) | $1.24 B(+13.2%) |
| Dec 2023 | $1.09 B(+37.8%) | $352.61 M(+19.6%) | $1.09 B(+12.9%) |
| Sep 2023 | - | $294.79 M(+29.8%) | $968.02 M(+12.1%) |
| Jun 2023 | - | $227.11 M(+4.0%) | $863.54 M(+3.8%) |
| Mar 2023 | - | $218.48 M(-4.0%) | $832.12 M(+4.9%) |
| Dec 2022 | $793.02 M(+31.1%) | $227.63 M(+19.6%) | $793.02 M(+7.9%) |
| Sep 2022 | - | $190.32 M(-2.7%) | $735.11 M(+3.4%) |
| Jun 2022 | - | $195.69 M(+9.1%) | $710.76 M(+7.7%) |
| Mar 2022 | - | $179.39 M(+5.7%) | $659.64 M(+9.1%) |
| Dec 2021 | $604.84 M(+26.9%) | $169.72 M(+2.3%) | $604.84 M(+8.4%) |
| Sep 2021 | - | $165.96 M(+14.8%) | $557.86 M(+7.1%) |
| Jun 2021 | - | $144.57 M(+16.0%) | $520.80 M(+4.1%) |
| Mar 2021 | - | $124.58 M(+1.5%) | $500.25 M(+4.9%) |
| Dec 2020 | $476.72 M(+47.0%) | $122.73 M(-4.8%) | $476.72 M(+8.7%) |
| Sep 2020 | - | $128.91 M(+3.9%) | $438.53 M(+10.8%) |
| Jun 2020 | - | $124.02 M(+22.7%) | $395.62 M(+12.9%) |
| Mar 2020 | - | $101.05 M(+19.5%) | $350.35 M(+8.1%) |
| Dec 2019 | $324.25 M(+21.5%) | $84.55 M(-1.7%) | $324.25 M(+4.3%) |
| Sep 2019 | - | $86.00 M(+9.2%) | $310.98 M(+5.5%) |
| Jun 2019 | - | $78.75 M(+5.1%) | $294.72 M(+4.2%) |
| Mar 2019 | - | $74.95 M(+5.1%) | $282.77 M(+6.0%) |
| Dec 2018 | $266.84 M(+81.2%) | $71.28 M(+2.2%) | $266.84 M(+7.0%) |
| Sep 2018 | - | $69.75 M(+4.4%) | $249.29 M(+12.1%) |
| Jun 2018 | - | $66.79 M(+13.2%) | $222.42 M(+17.0%) |
| Mar 2018 | - | $59.02 M(+9.8%) | $190.13 M(+29.1%) |
| Dec 2017 | $147.23 M(+2667.5%) | $53.73 M(+25.3%) | $147.23 M(+49.0%) |
| Sep 2017 | - | $42.88 M(+24.3%) | $98.82 M(+76.6%) |
| Jun 2017 | - | $34.51 M(+114.1%) | $55.94 M(+160.9%) |
| Mar 2017 | - | $16.12 M(+203.0%) | $21.44 M(+303.0%) |
| Dec 2016 | $5.32 M | $5.32 M(>+9900.0%) | $5.32 M(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2016 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2015 | $1.25 M(-87.2%) | - | - |
| Dec 2014 | $9.76 M(-44.5%) | - | - |
| Sep 2011 | - | $7.52 M(-35.1%) | $33.41 M(-3.4%) |
| Jun 2011 | - | $11.59 M(-19.0%) | $34.58 M(+28.1%) |
| Mar 2011 | - | $14.30 M(+64.3%) | $27.00 M(+41.8%) |
| Sep 2010 | - | $8.70 M(+117.7%) | $19.04 M(+14.1%) |
| Jun 2010 | - | $4.00 M(+231.7%) | $16.69 M(+6.7%) |
| Mar 2010 | - | $1.21 M(-76.5%) | $15.64 M(-11.1%) |
| Dec 2009 | $17.59 M(-17.3%) | $5.14 M(-19.1%) | $17.59 M(+41.3%) |
| Sep 2009 | - | $6.35 M(+115.7%) | $12.45 M(+104.2%) |
| Jun 2009 | - | $2.94 M(-6.5%) | $6.09 M(-25.1%) |
| Mar 2009 | - | $3.15 M(-36.8%) | $8.13 M(-23.3%) |
| Dec 2008 | $21.26 M(+1140.4%) | - | - |
| Jun 2008 | - | $4.98 M(-11.4%) | $10.61 M(+88.6%) |
| Mar 2008 | - | $5.63 M(+2626.6%) | $5.63 M(+228.2%) |
| Dec 2000 | $1.71 M(+328.4%) | $206.30 K(-1.1%) | $1.71 M(+0.4%) |
| Sep 2000 | - | $208.70 K(+121.5%) | $1.71 M(+6.8%) |
| Jun 2000 | - | $94.20 K(-92.2%) | $1.60 M(+6.3%) |
| Mar 2000 | - | $1.20 M(+502.3%) | $1.50 M(+200.9%) |
| Dec 1999 | $400.00 K(+33.3%) | $200.00 K(+100.0%) | $500.00 K(+66.7%) |
| Sep 1999 | - | $100.00 K(-50.0%) | $300.00 K(-50.0%) |
| Mar 1999 | - | $200.00 K(>+9900.0%) | $600.00 K(0.0%) |
| Dec 1998 | $300.00 K(-50.0%) | $0.00(-100.0%) | $600.00 K(-25.0%) |
| Sep 1998 | - | $200.00 K(0.0%) | $800.00 K(+33.3%) |
| Jun 1998 | - | $200.00 K(0.0%) | $600.00 K(-14.3%) |
| Mar 1998 | - | $200.00 K(0.0%) | $700.00 K(0.0%) |
| Dec 1997 | $600.00 K(0.0%) | $200.00 K(-33.3%) | $700.00 K(+40.0%) |
| Jun 1997 | - | $300.00 K(+50.0%) | $500.00 K(+150.0%) |
| Mar 1997 | - | $200.00 K | $200.00 K |
| Dec 1996 | $600.00 K | - | - |
FAQ
- What is Sarepta Therapeutics annual gross profit?
- What is the all time high annual gross profit for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual gross profit year-on-year change?
- What is Sarepta Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly gross profit year-on-year change?
- What is Sarepta Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for Sarepta Therapeutics?
- What is Sarepta Therapeutics TTM gross profit year-on-year change?
What is Sarepta Therapeutics annual gross profit?
The current annual gross profit of SRPT is $1.09 B
What is the all time high annual gross profit for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual gross profit is $1.09 B
What is Sarepta Therapeutics annual gross profit year-on-year change?
Over the past year, SRPT annual gross profit has changed by +$299.97 M (+37.83%)
What is Sarepta Therapeutics quarterly gross profit?
The current quarterly gross profit of SRPT is $375.48 M
What is the all time high quarterly gross profit for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly gross profit is $375.48 M
What is Sarepta Therapeutics quarterly gross profit year-on-year change?
Over the past year, SRPT quarterly gross profit has changed by $0.00 (0.00%)
What is Sarepta Therapeutics TTM gross profit?
The current TTM gross profit of SRPT is $1.41 B
What is the all time high TTM gross profit for Sarepta Therapeutics?
Sarepta Therapeutics all-time high TTM gross profit is $1.41 B
What is Sarepta Therapeutics TTM gross profit year-on-year change?
Over the past year, SRPT TTM gross profit has changed by $0.00 (0.00%)